Cargando…

Low Glucose Mediated Fluconazole Tolerance in Cryptococcus neoformans

Chronic meningoencephalitis is caused by Cryptococcus neoformans and is treated in many parts of the world with fluconazole (FLC) monotherapy, which is associated with treatment failure and poor outcome. In the host, C. neoformans propagates predominantly under low glucose growth conditions. We inve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhattacharya, Somanon, Oliveira, Natalia Kronbauer, Savitt, Anne G., Silva, Vanessa K. A., Krausert, Rachel B., Ghebrehiwet, Berhane, Fries, Bettina C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8233753/ https://www.ncbi.nlm.nih.gov/pubmed/34207384 http://dx.doi.org/10.3390/jof7060489

Ejemplares similares

Novel ABC Transporter Associated with Fluconazole Resistance in Aging of Cryptococcus neoformans
por: Oliveira, Natalia Kronbauer, et al.
Publicado: (2022)

851. Metabolic Changes Contributing to Age-Associated Antifungal Tolerance in Cryptococcus neoformans
por: Yoo, Kyungyoon, et al.
Publicado: (2023)

Replicative Aging Remodels the Cell Wall and Is Associated with Increased Intracellular Trafficking in Human Pathogenic Yeasts
por: Silva, Vanessa K. A., et al.
Publicado: (2022)

High-Throughput Yeast Aging Analysis for Cryptococcus (HYAAC) microfluidic device streamlines aging studies in Cryptococcus neoformans
por: Orner, Erika P., et al.
Publicado: (2019)

Cell Wall-Associated Virulence Factors Contribute to Increased Resilience of Old Cryptococcus neoformans Cells
por: Orner, Erika P., et al.
Publicado: (2019)

Gene Duplication Associated with Increased Fluconazole Tolerance in Candida auris cells of Advanced Generational Age
por: Bhattacharya, Somanon, et al.
Publicado: (2019)

Impact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates
por: Rossi, Suélen A., et al.
Publicado: (2016)

Coregulation of extracellular vesicle production and fluconazole susceptibility in Cryptococcus neoformans
por: Rizzo, Juliana, et al.
Publicado: (2023)

Corrigendum: Impact of Resistance to Fluconazole on Virulence and Morphological Aspects of Cryptococcus neoformans and Cryptococcus gattii Isolates
por: Rossi, Suélen A., et al.
Publicado: (2016)

Fluconazole induces ROS in Cryptococcus neoformans and contributes to DNA damage in vitro
por: Peng, Congyue Annie, et al.
Publicado: (2018)

Effects of environmental factors on sensitivity of Cryptococcus neoformans to fluconazole and amphotericin B
por: Carlson, Tyler, et al.
Publicado: (2021)

Modulation of Replicative Lifespan in Cryptococcus neoformans: Implications for Virulence
por: Bouklas, Tejas, et al.
Publicado: (2017)

Colony and Single Cell Level Analysis of the Heterogeneous Response of Cryptococcus neoformans to Fluconazole
por: Altamirano, Sophie, et al.
Publicado: (2018)

Necrotizing fasciitis as the initial presentation of disseminated infection with fluconazole-resistant Cryptococcus neoformans
por: Richardson, Timothy E, et al.
Publicado: (2014)

Antiphagocytic protein 1 increases the susceptibility of Cryptococcus neoformans to amphotericin B and fluconazole
por: Ghaffar, Muhammad, et al.
Publicado: (2019)

Increase of reactive oxygen species contributes to growth inhibition by fluconazole in Cryptococcus neoformans
por: Dbouk, Nadir Hani, et al.
Publicado: (2019)

Differences in Sirtuin Regulation in Response to Calorie Restriction in Cryptococcus neoformans
por: Bouklas, Tejas, et al.
Publicado: (2018)

The Role of Ceramide Synthases in the Pathogenicity of Cryptococcus neoformans
por: Munshi, Mansa A., et al.
Publicado: (2018)

Characterization of the Chromosome 4 Genes That Affect Fluconazole-Induced Disomy Formation in Cryptococcus neoformans
por: Ngamskulrungroj, Popchai, et al.
Publicado: (2012)

Old Cryptococcus neoformans Cells Contribute to Virulence in Chronic Cryptococcosis
por: Bouklas, Tejas, et al.
Publicado: (2013)

Minocycline and Fluconazole Have a Synergistic Effect Against Cryptococcus neoformans Both in vitro and in vivo
por: Kong, Qinxiang, et al.
Publicado: (2020)

Decreasing fluconazole susceptibility of clinical South African Cryptococcus neoformans isolates over a decade
por: Naicker, Serisha D., et al.
Publicado: (2020)

Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans
por: Yang, Feng, et al.
Publicado: (2021)

Combined effect of furanone fluconazole and amphotericin B against biofilms formed from Cryptococcus neoformans
por: Meenakumari, Kirishnamoorthy, et al.
Publicado: (2021)

S8.5d Cryptococcus neoformans and Cryptococcus gattii clinical isolates from Colombia develop heteroresistance to fluconazole at high concentrations
por: Melendres, Javier, et al.
Publicado: (2022)

Genome-wide expression profiling of the response to short-term exposure to fluconazole in Cryptococcus neoformans serotype A
por: Florio, Ada Rita, et al.
Publicado: (2011)

Fluconazole-Induced Ploidy Change in Cryptococcus neoformans Results from the Uncoupling of Cell Growth and Nuclear Division
por: Altamirano, Sophie, et al.
Publicado: (2017)

etymologia: Cryptococcus neoformans
Publicado: (2008)

The capsule of Cryptococcus neoformans
por: Casadevall, Arturo, et al.
Publicado: (2018)

Deletion of Cryptococcus neoformans AIF Ortholog Promotes Chromosome Aneuploidy and Fluconazole-Resistance in a Metacaspase-Independent Manner
por: Semighini, Camile P., et al.
Publicado: (2011)

Triclosan Demonstrates Synergic Effect with Amphotericin B and Fluconazole and Induces Apoptosis-Like Cell Death in Cryptococcus neoformans
por: Movahed, Elaheh, et al.
Publicado: (2016)

The combination of tamoxifen with amphotericin B, but not with fluconazole, has synergistic activity against the majority of clinical isolates of Cryptococcus neoformans
por: Hai, Trieu Phan, et al.
Publicado: (2019)

Overexpression of TUF1 restores respiratory growth and fluconazole sensitivity to a Cryptococcus neoformans vad1Δ mutant
por: Panepinto, John C., et al.
Publicado: (2010)

Increasing trend of fluconazole-non-susceptible Cryptococcus neoformans in patients with invasive cryptococcosis: a 12-year longitudinal study
por: Chen, Yi-Chun, et al.
Publicado: (2015)

Cryptococcus neoformans, Unlike Candida albicans, Forms Aneuploid Clones Directly from Uninucleated Cells under Fluconazole Stress
por: Chang, Yun C., et al.
Publicado: (2018)

ATI-2307 Exhibits Equivalent Antifungal Activity in Cryptococcus neoformans Clinical Isolates With High and Low Fluconazole IC(50)
por: Gerlach, Elliot S., et al.
Publicado: (2021)

Lack of Association between Fluconazole Susceptibility and ERG11 Nucleotide Polymorphisms in Cryptococcus neoformans Clinical Isolates from Uganda
por: Atim, Priscilla Belbir, et al.
Publicado: (2022)

P092 Otilonium bromide is a potent antifungal agent against fluconazole- and flucytosine-resistant Cryptococcus neoformans strains
por: Zhen, Cheng, et al.
Publicado: (2022)

Cryptococcus neoformans–Specific and Non–Cryptococcus neoformans–Specific Antibody Profiles in Organ Transplant Recipients With and Without Cryptococcosis
por: Yoon, Hyunah, et al.
Publicado: (2022)

Antifungal Susceptibilities of Cryptococcus neoformans
por: Archibald, Lennox K., et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_lqon7tukeo7pl0ls1u3i75cr65